SCOPUS 정보 검색 플랫폼

Nature Reviews Neurology

Volumn 9, Issue 1, 2013, Pages 8-10

Multiple sclerosis: Oral BG12 for treatment of relapsing-remitting MS

(1) Limmroth, Volker a

a UNIVERSITY OF COLOGNE (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; FINGOLIMOD; FUMARIC ACID DIMETHYL ESTER; GLATIRAMER; INTERFERON; PLACEBO;

ANTIINFLAMMATORY ACTIVITY; AUTOIMMUNE DISEASE; CELL PROTECTION; DIARRHEA; DISEASE ACTIVITY; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EXPANDED DISABILITY STATUS SCALE; FLUSHING; GASTROINTESTINAL SYMPTOM; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK REDUCTION; SIDE EFFECT; UPPER ABDOMINAL PAIN;

ADMINISTRATION, ORAL; BRAIN; CLINICAL TRIALS, PHASE III AS TOPIC; DISABILITY EVALUATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; FUMARATES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, SUBCUTANEOUS; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PEPTIDES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84871928956 PISSN: 17594758 EISSN: 17594766 Source Type: Journal
DOI: 10.1038/nrneurol.2012.231 Document Type: Note

Times cited : (11)

References (6)

1
- 54149084585
- Multiple sclerosis
- Compston, A. & Coles, A. Multiple sclerosis. Lancet 372, 1502-1517 (2008).
- (2008) Lancet , vol.372 , pp. 1502-1517
- Compston, A.¹ Coles, A.²

2
- 70449253356
- Treatment of psoriasis vulgaris [german]
- Schweckendiek, W. Treatment of psoriasis vulgaris [German]. Med. Monatsschr. 13, 103-104 (1959).
- (1959) Med. Monatsschr. , vol.13 , pp. 103-104
- Schweckendiek, W.¹

3
- 33745051595
- Oral fumaric acid esters for the treatment of active multiple sclerosis: An open-label, baseline-controlled pilot study
- Schimrigk, S. et al. Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study. Eur. J. Neurol. 13, 604-610 (2006).
- (2006) Eur. J. Neurol. , vol.13 , pp. 604-610
- Schimrigk, S.¹

4
- 54149116366
- Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: A multicentre, randomised, double-blind, placebo-controlled phase IIb study
- Kappos, L. et al. Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study. Lancet 372, 1463-1472 (2008).
- (2008) Lancet , vol.372 , pp. 1463-1472
- Kappos, L.¹

5
- 84866423965
- Placebo-controlled phase 3 study of oral BG12 for relapsing multiple sclerosis
- Gold, R. et al. Placebo-controlled phase 3 study of oral BG12 for relapsing multiple sclerosis. N. Engl. J. Med. 376, 1098-1107 (2012).
- (2012) N. Engl. J. Med. , vol.376 , pp. 1098-1107
- Gold, R.¹

6
- 84866355653
- Placebo-controlled phase 3 study of oral BG12 or glatiramer in multiple sclerosis
- Fox, R. J. et al. Placebo-controlled phase 3 study of oral BG12 or glatiramer in multiple sclerosis. N. Engl. J. Med. 376, 1087-1097 (2012).
- (2012) N. Engl. J. Med. , vol.376 , pp. 1087-1097
- Fox, R.J.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.